$GEB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INOVIO PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in INOVIO PHARMACEUTICALS, INC.. Get notifications about new insider transactions in INOVIO PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 21 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Sell | S | 8.52 | 10,000 | 85,200 | 160,788 | 170.8 K to 160.8 K (-5.86 %) |
Apr 21 2021 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | M | 2.40 | 22,500 | 54,000 | 0 | |
Apr 21 2021 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Sell | S | 8.54 | 4,083 | 34,869 | 851,136 | 855.2 K to 851.1 K (-0.48 %) |
Apr 21 2021 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Sell | S | 8.57 | 22,500 | 192,825 | 855,219 | 877.7 K to 855.2 K (-2.56 %) |
Apr 21 2021 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Buy | M | 2.40 | 22,500 | 54,000 | 877,719 | 855.2 K to 877.7 K (+2.63 %) |
Apr 16 2021 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | M | 3.56 | 2,000 | 7,120 | 0 | |
Apr 16 2021 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Sell | S | 8.75 | 2,000 | 17,500 | 51,650 | 53.7 K to 51.7 K (-3.73 %) |
Apr 16 2021 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Buy | M | 3.56 | 2,000 | 7,120 | 53,650 | 51.7 K to 53.7 K (+3.87 %) |
Mar 26 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Option Exercise | M | 0.00 | 16,667 | 0 | 16,666 | |
Mar 26 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Sell | S | 8.97 | 4,710 | 42,249 | 60,127 | 64.8 K to 60.1 K (-7.26 %) |
Mar 26 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Payment of Exercise | F | 9.06 | 7,247 | 65,658 | 64,837 | 72.1 K to 64.8 K (-10.05 %) |
Mar 26 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Buy | M | 0.00 | 16,667 | 0 | 72,084 | 55.4 K to 72.1 K (+30.08 %) |
Mar 23 2021 | GEB | INOVIO PHARMACEUTI ... | Miller Ann Calby | Director | Option Exercise | M | 0.00 | 4,274 | 0 | 4,273 | |
Mar 23 2021 | GEB | INOVIO PHARMACEUTI ... | Miller Ann Calby | Director | Option Exercise | M | 0.00 | 4,274 | 0 | 4,273 | |
Mar 23 2021 | GEB | INOVIO PHARMACEUTI ... | Miller Ann Calby | Director | Buy | M | 0.00 | 4,274 | 0 | 16,561 | 12.3 K to 16.6 K (+34.78 %) |
Mar 23 2021 | GEB | INOVIO PHARMACEUTI ... | Miller Ann Calby | Director | Buy | M | 0.00 | 4,274 | 0 | 16,561 | 12.3 K to 16.6 K (+34.78 %) |
Mar 16 2021 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | M | 3.56 | 2,000 | 7,120 | 2,000 | |
Mar 16 2021 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Sell | S | 10.41 | 2,000 | 20,820 | 51,650 | 53.7 K to 51.7 K (-3.73 %) |
Mar 16 2021 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Buy | M | 3.56 | 2,000 | 7,120 | 53,650 | 51.7 K to 53.7 K (+3.87 %) |
Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 59,737 | 0 | 119,474 | |
Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 10.57 | 31,410 | 332,004 | 170,788 | 202.2 K to 170.8 K (-15.53 %) |
Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 59,737 | 0 | 202,198 | 142.5 K to 202.2 K (+41.93 %) |
Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Option Exercise | M | 0.00 | 59,737 | 0 | 119,474 | |
Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Payment of Exercise | F | 10.57 | 25,967 | 274,471 | 89,222 | 115.2 K to 89.2 K (-22.54 %) |
Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Buy | M | 0.00 | 59,737 | 0 | 115,189 | 55.5 K to 115.2 K (+107.73 %) |
Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | M | 0.00 | 11,667 | 0 | 23,333 | |
Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Buy | M | 0.00 | 11,667 | 0 | 855,219 | 843.6 K to 855.2 K (+1.38 %) |
Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | M | 0.00 | 139,387 | 0 | 278,773 | |
Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Payment of Exercise | F | 10.57 | 74,545 | 787,941 | 1,228,658 | 1.3 M to 1.2 M (-5.72 %) |
Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | M | 0.00 | 139,387 | 0 | 1,303,203 | 1.2 M to 1.3 M (+11.98 %) |
Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Option Exercise | M | 0.00 | 59,737 | 0 | 119,474 | |
Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Sell | S | 10.06 | 16,881 | 169,823 | 55,417 | 72.3 K to 55.4 K (-23.35 %) |
Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Payment of Exercise | F | 10.57 | 25,974 | 274,545 | 72,298 | 98.3 K to 72.3 K (-26.43 %) |
Mar 12 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Buy | M | 0.00 | 59,737 | 0 | 98,272 | 38.5 K to 98.3 K (+155.02 %) |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | M | 0.00 | 63,700 | 0 | 63,700 | |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | M | 0.00 | 120,100 | 0 | 0 | |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Payment of Exercise | F | 8.91 | 34,067 | 303,537 | 1,163,816 | 1.2 M to 1.2 M (-2.84 %) |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | M | 0.00 | 63,700 | 0 | 1,197,883 | 1.1 M to 1.2 M (+5.62 %) |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Payment of Exercise | F | 9.19 | 64,230 | 590,274 | 1,134,183 | 1.2 M to 1.1 M (-5.36 %) |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | M | 0.00 | 120,100 | 0 | 1,198,413 | 1.1 M to 1.2 M (+11.14 %) |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Option Exercise | M | 0.00 | 19,900 | 0 | 19,900 | |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Option Exercise | M | 0.00 | 27,566 | 0 | 0 | |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Payment of Exercise | F | 8.91 | 6,882 | 61,319 | 55,452 | 62.3 K to 55.5 K (-11.04 %) |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Buy | M | 0.00 | 19,900 | 0 | 62,334 | 42.4 K to 62.3 K (+46.90 %) |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Payment of Exercise | F | 9.19 | 9,632 | 88,518 | 42,434 | 52.1 K to 42.4 K (-18.50 %) |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Buy | M | 0.00 | 27,566 | 0 | 52,066 | 24.5 K to 52.1 K (+112.51 %) |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | M | 0.00 | 11,667 | 0 | 11,666 | |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | M | 0.00 | 11,666 | 0 | 0 | |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Sell | S | 9.60 | 3,500 | 33,601 | 843,552 | 847.1 K to 843.6 K (-0.41 %) |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Buy | M | 0.00 | 11,667 | 0 | 847,052 | 835.4 K to 847.1 K (+1.40 %) |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Sell | S | 9.18 | 3,500 | 32,135 | 835,385 | 838.9 K to 835.4 K (-0.42 %) |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Buy | M | 0.00 | 11,666 | 0 | 838,885 | 827.2 K to 838.9 K (+1.41 %) |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 21,467 | 0 | 21,466 | |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 0.00 | 27,566 | 0 | 0 | |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 8.91 | 11,288 | 100,576 | 142,461 | 153.7 K to 142.5 K (-7.34 %) |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 21,467 | 0 | 153,749 | 132.3 K to 153.7 K (+16.23 %) |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Payment of Exercise | F | 9.19 | 14,574 | 133,935 | 132,282 | 146.9 K to 132.3 K (-9.92 %) |
Mar 09 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 0.00 | 27,566 | 0 | 146,856 | 119.3 K to 146.9 K (+23.11 %) |
Feb 26 2021 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
Feb 26 2021 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | A | 11.10 | 60,000 | 666,000 | 60,000 | |
Feb 26 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 0.00 | 67,633 | 0 | 67,633 | |
Feb 26 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | A | 11.10 | 104,833 | 1,163,646 | 104,833 | |
Feb 26 2021 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | A | 0.00 | 206,300 | 0 | 206,300 | |
Feb 26 2021 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | A | 11.10 | 319,800 | 3,549,780 | 319,800 | |
Feb 26 2021 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Option Exercise | A | 0.00 | 67,633 | 0 | 67,633 | |
Feb 26 2021 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Option Exercise | A | 11.10 | 104,833 | 1,163,646 | 104,833 | |
Feb 26 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Option Exercise | A | 0.00 | 67,633 | 0 | 67,633 | |
Feb 26 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Option Exercise | A | 11.10 | 104,833 | 1,163,646 | 104,833 | |
Feb 18 2021 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | M | 3.56 | 2,000 | 7,120 | 4,000 | |
Feb 18 2021 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Sell | S | 14.68 | 2,000 | 29,360 | 51,650 | 53.7 K to 51.7 K (-3.73 %) |
Feb 18 2021 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Buy | M | 3.56 | 2,000 | 7,120 | 53,650 | 51.7 K to 53.7 K (+3.87 %) |
Feb 03 2021 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | M | 4.56 | 62,500 | 285,000 | 0 | |
Feb 03 2021 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Sell | S | 14.24 | 62,500 | 890,000 | 1,078,313 | 1.1 M to 1.1 M (-5.48 %) |
Feb 03 2021 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | M | 4.56 | 62,500 | 285,000 | 1,140,813 | 1.1 M to 1.1 M (+5.80 %) |
Feb 03 2021 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Sell | S | 15.00 | 100,000 | 1,500,000 | 1,078,313 | 1.2 M to 1.1 M (-8.49 %) |
Feb 03 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Option Exercise | M | 3.62 | 22,376 | 81,001 | 100,000 | |
Feb 03 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Sell | S | 15.00 | 5,960 | 89,400 | 38,535 | 44.5 K to 38.5 K (-13.39 %) |
Feb 03 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Sell | S | 15.06 | 22,376 | 336,983 | 44,495 | 66.9 K to 44.5 K (-33.46 %) |
Feb 03 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Buy | M | 3.62 | 22,376 | 81,001 | 66,871 | 44.5 K to 66.9 K (+50.29 %) |
Jan 29 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Option Exercise | M | 3.62 | 55,248 | 199,998 | 122,376 | |
Jan 29 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Option Exercise | M | 3.62 | 22,376 | 81,001 | 177,624 | |
Jan 29 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Sell | S | 12.04 | 16,713 | 201,225 | 44,495 | 61.2 K to 44.5 K (-27.31 %) |
Jan 29 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Buy | M | 3.62 | 55,248 | 199,998 | 61,208 | 6 K to 61.2 K (+926.98 %) |
Jan 29 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Sell | S | 12.04 | 5,960 | 71,758 | 5,960 | 11.9 K to 6 K (-50.00 %) |
Jan 29 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Sell | S | 12.01 | 22,376 | 268,736 | 11,920 | 34.3 K to 11.9 K (-65.24 %) |
Jan 29 2021 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Buy | M | 3.62 | 22,376 | 81,001 | 34,296 | 11.9 K to 34.3 K (+187.72 %) |
Jan 15 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 4.56 | 30,000 | 136,800 | 0 | |
Jan 15 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Sell | S | 10.02 | 30,000 | 300,558 | 119,290 | 149.3 K to 119.3 K (-20.10 %) |
Jan 15 2021 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 4.56 | 30,000 | 136,800 | 149,290 | 119.3 K to 149.3 K (+25.15 %) |
Jan 15 2021 | GEB | INOVIO PHARMACEUTI ... | Shepard Jay | Director | Option Exercise | M | 0.00 | 4,274 | 0 | 8,547 | |
Jan 15 2021 | GEB | INOVIO PHARMACEUTI ... | Shepard Jay | Director | Buy | M | 0.00 | 4,274 | 0 | 4,274 | 0 to 4.3 K |
Dec 31 2020 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Gift | G | 0.00 | 10,000 | 0 | 1,178,313 | 1.2 M to 1.2 M (-0.84 %) |
Dec 17 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 2.16 | 11,250 | 24,300 | 33,750 | |
Dec 17 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 2.40 | 8,750 | 21,000 | 0 | |
Dec 17 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Sell | S | 10.69 | 20,000 | 213,706 | 119,290 | 139.3 K to 119.3 K (-14.36 %) |
Dec 17 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 2.16 | 11,250 | 24,300 | 139,290 | 128 K to 139.3 K (+8.79 %) |
Dec 17 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 2.40 | 8,750 | 21,000 | 128,040 | 119.3 K to 128 K (+7.34 %) |
Dec 17 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | M | 4.56 | 17,500 | 79,800 | 0 | |
Dec 17 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Sell | S | 10.71 | 17,500 | 187,352 | 827,219 | 844.7 K to 827.2 K (-2.07 %) |
Dec 17 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Buy | M | 4.56 | 17,500 | 79,800 | 844,719 | 827.2 K to 844.7 K (+2.12 %) |
Nov 12 2020 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Sell | S | 9.75 | 19,466 | 189,794 | 24,500 | 44 K to 24.5 K (-44.28 %) |
Aug 12 2020 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Sell | S | 19.06 | 19,467 | 371,004 | 43,966 | 63.4 K to 44 K (-30.69 %) |
Jul 31 2020 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Sell | S | 21.13 | 100,000 | 2,113,450 | 1,188,313 | 1.3 M to 1.2 M (-7.76 %) |
Jul 17 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Option Exercise | M | 2.40 | 35,000 | 84,000 | 0 | |
Jul 17 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Sell | S | 24.95 | 35,000 | 873,208 | 119,290 | 154.3 K to 119.3 K (-22.68 %) |
Jul 17 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Buy | M | 2.40 | 35,000 | 84,000 | 154,290 | 119.3 K to 154.3 K (+29.34 %) |
Jul 02 2020 | GEB | INOVIO PHARMACEUTI ... | KIES PETER | CFO | Sell | S | 26.50 | 35,000 | 927,500 | 119,290 | 154.3 K to 119.3 K (-22.68 %) |
Jun 24 2020 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Sell | S | 14.70 | 19,467 | 286,165 | 63,433 | 82.9 K to 63.4 K (-23.48 %) |
May 20 2020 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | M | 4.60 | 8,750 | 40,250 | 0 | |
May 20 2020 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Sell | S | 15.95 | 8,750 | 139,594 | 51,650 | 60.4 K to 51.7 K (-14.49 %) |
May 20 2020 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Buy | M | 4.60 | 8,750 | 40,250 | 60,400 | 51.7 K to 60.4 K (+16.94 %) |
May 15 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | A | 0.00 | 8,700 | 0 | 8,700 | |
May 15 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | A | 13.65 | 13,300 | 181,545 | 13,300 | |
May 15 2020 | GEB | INOVIO PHARMACEUTI ... | Miller Ann Calby | Director | Option Exercise | A | 0.00 | 8,700 | 0 | 8,700 | |
May 15 2020 | GEB | INOVIO PHARMACEUTI ... | Miller Ann Calby | Director | Option Exercise | A | 13.65 | 13,300 | 181,545 | 13,300 | |
May 15 2020 | GEB | INOVIO PHARMACEUTI ... | Zoth Lota S. | Director | Option Exercise | A | 0.00 | 8,700 | 0 | 8,700 | |
May 15 2020 | GEB | INOVIO PHARMACEUTI ... | Zoth Lota S. | Director | Option Exercise | A | 13.65 | 13,300 | 181,545 | 13,300 | |
May 15 2020 | GEB | INOVIO PHARMACEUTI ... | Shepard Jay | Director | Option Exercise | A | 0.00 | 8,700 | 0 | 8,700 | |
May 15 2020 | GEB | INOVIO PHARMACEUTI ... | Shepard Jay | Director | Option Exercise | A | 13.65 | 13,300 | 181,545 | 13,300 | |
May 12 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Sell | S | 11.84 | 2,404 | 28,463 | 827,219 | 829.6 K to 827.2 K (-0.29 %) |
May 08 2020 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Option Exercise | M | 0.00 | 8,013 | 0 | 0 | |
May 08 2020 | GEB | INOVIO PHARMACEUTI ... | BENITO SIMON X | Director | Buy | M | 0.00 | 8,013 | 0 | 51,650 | 43.6 K to 51.7 K (+18.36 %) |
May 08 2020 | GEB | INOVIO PHARMACEUTI ... | Zoth Lota S. | Director | Option Exercise | M | 0.00 | 8,013 | 0 | 0 | |
May 08 2020 | GEB | INOVIO PHARMACEUTI ... | Zoth Lota S. | Director | Buy | M | 0.00 | 8,013 | 0 | 12,103 | 4.1 K to 12.1 K (+195.92 %) |
May 08 2020 | GEB | INOVIO PHARMACEUTI ... | YARNO WENDY L | Director | Option Exercise | M | 0.00 | 8,013 | 0 | 0 | |
May 08 2020 | GEB | INOVIO PHARMACEUTI ... | YARNO WENDY L | Director | Buy | M | 0.00 | 8,013 | 0 | 24,363 | 16.4 K to 24.4 K (+49.01 %) |
May 08 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Option Exercise | M | 0.00 | 8,013 | 0 | 0 | |
May 08 2020 | GEB | INOVIO PHARMACEUTI ... | Weiner David B. | Director | Buy | M | 0.00 | 8,013 | 0 | 829,623 | 821.6 K to 829.6 K (+0.98 %) |
May 08 2020 | GEB | INOVIO PHARMACEUTI ... | Miller Ann Calby | Director | Option Exercise | M | 0.00 | 8,013 | 0 | 0 | |
May 08 2020 | GEB | INOVIO PHARMACEUTI ... | Miller Ann Calby | Director | Buy | M | 0.00 | 8,013 | 0 | 12,287 | 4.3 K to 12.3 K (+187.48 %) |
May 08 2020 | GEB | INOVIO PHARMACEUTI ... | Cabrera Angel | Director | Option Exercise | M | 0.00 | 8,013 | 0 | 0 | |
May 08 2020 | GEB | INOVIO PHARMACEUTI ... | Cabrera Angel | Director | Buy | M | 0.00 | 8,013 | 0 | 75,602 | 67.6 K to 75.6 K (+11.86 %) |
Mar 26 2020 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Option Exercise | M | 0.00 | 16,667 | 0 | 33,333 | |
Mar 26 2020 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Payment of Exercise | F | 6.68 | 4,747 | 31,710 | 11,920 | 16.7 K to 11.9 K (-28.48 %) |
Mar 26 2020 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Buy | M | 0.00 | 16,667 | 0 | 16,667 | 0 to 16.7 K |
Mar 23 2020 | GEB | INOVIO PHARMACEUTI ... | Miller Ann Calby | Director | Option Exercise | M | 0.00 | 4,274 | 0 | 8,547 | |
Mar 23 2020 | GEB | INOVIO PHARMACEUTI ... | Miller Ann Calby | Director | Buy | M | 0.00 | 4,274 | 0 | 4,274 | 0 to 4.3 K |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | A | 0.00 | 418,160 | 0 | 418,160 | |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | M | 0.00 | 105,700 | 0 | 0 | |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Payment of Exercise | F | 5.70 | 36,826 | 209,908 | 1,288,313 | 1.3 M to 1.3 M (-2.78 %) |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | M | 0.00 | 105,700 | 0 | 1,325,139 | 1.2 M to 1.3 M (+8.67 %) |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | A | 0.00 | 418,160 | 0 | 418,160 | |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Option Exercise | M | 0.00 | 105,700 | 0 | 0 | |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Payment of Exercise | F | 5.70 | 36,826 | 209,908 | 1,288,313 | 1.3 M to 1.3 M (-2.78 %) |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Kim Jong Joseph | Chief Executive Off ... | Buy | M | 0.00 | 105,700 | 0 | 1,325,139 | 1.2 M to 1.3 M (+8.67 %) |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Option Exercise | A | 0.00 | 179,211 | 0 | 179,211 | |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Shea Jacqueline Elizabeth | Chief Operating Off ... | Option Exercise | A | 0.00 | 179,211 | 0 | 179,211 | |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Option Exercise | A | 0.00 | 179,211 | 0 | 179,211 | |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Option Exercise | M | 0.00 | 2,812 | 0 | 0 | |
Mar 12 2020 | GEB | INOVIO PHARMACEUTI ... | Humeau Laurent | Chief Scientific Of ... | Payment of Exercise | F | 5.70 | 973 | 5,546 | 82,900 | 83.9 K to 82.9 K (-1.16 %) |